NYTech
People
Personemployee
P

Meg Alexander

President and Chief Executive Officer at Ovid Therapeutics

LinkedIn profile Suggest an update

Overview

Meg Alexander serves as President and Chief Executive Officer at Ovid Therapeutics [1]. Alexander is a biotech professional who has advanced more than two dozen therapies from development to market and has led complex initiatives across prominent industry companies [2]. Alexander joined Ovid Therapeutics as Vice President in July 2021 [7], subsequently holding roles as Chief Corporate Affairs Officer and Chief Strategy Officer [5][6] before becoming President and Chief Operating Officer in September 2024 [4]. Alexander assumed the position of President and Chief Executive Officer in January 2026 [3]. In this role, Alexander leads enterprise operations and has directed the company's evolution toward a clinically driven organization focused on neurological diseases [2]. Alexander previously founded and managed a Reputation and Risk Management Practice at Syneos Health from 2015 to 2020 [8] and held a position as Practice Head for Risk Mitigation and Issues Management at inVentiv Health Public Relations Group [9]. Alexander holds a Bachelor of Business Administration in Marketing from William & Mary [10].

Profile introduction
Source excerptLinkedIn [2]

Meg Alexander is an experienced biotech builder who has played a critical role in advancing more than two dozen therapies from development to market. She has consistently led complex initiatives and cross-functional teams, playing a key role in driving growth and strategic transformation at some of the industry’s most prominent companies. As President and Chief Executive Officer of Ovid Therapeutics, she leads enterprise operations and has spearheaded the company’s evolution into a focused, clinically driven organization delivering innovation for patients with intractable neurological diseases…

Career history

  1. President and Chief Executive OfficerJan 2026 to presentOvid Therapeutics
  2. President & COOSep 2024 to Jan 2026Ovid Therapeutics
  3. Chief Strategy OfficerMay 2023 to Aug 2024Ovid Therapeutics
  4. Chief Corporate Affairs OfficerFeb 2022 to Aug 2024Ovid Therapeutics
  5. Vice PresidentJul 2021 to Aug 2024Ovid Therapeutics
  6. Founder & Managing Director, Reputation & Risk Management PracticeJan 2015 to Jun 2020Syneos Health (Previously INC Research/inVentiv Health)
  7. Practice Head, Risk Mitigation & Issues ManagementDec 2007 to Dec 2014inVentiv Health Public Relations Group

Education

  1. Bachelor of Business Administration, Marketing1999 - 2003William & Mary

This page shows public professional information only, each fact cited. Is this you? send a correction, or ask for removal within 24 hours, no questions asked.